Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

ABSTRACT: HCC827 cells were grown in gradually increasing concentrations of cetuximab beginning at 0.1 ug/ml. Drug concentrations were slowly increased until the resistant cells were able to proliferate in 100 ug/ml of cetuximab. Individual clones of cetuximab resistant (CR; CR1 to CR4) cells were isolated and confirmed to be drug resistant. Number of samples: 5. Parental HCC827 as a control. 4 Cetuximab resistant clones

ORGANISM(S): Homo sapiens

SUBMITTER: Pasi Jänne 

PROVIDER: E-GEOD-30255 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress